PROQR THERAPEUTICS NV (PRQR)

NL0010872495 - Common Stock

2.76  +0.02 (+0.73%)

After market: 2.76 0 (0%)

News Image
a month ago - ProQR Therapeutics N.V.

ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to...

News Image
2 months ago - ProQR Therapeutics N.V.

ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement

LEIDEN, the Netherlands and CAMBRIDGE, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to...

News Image
3 months ago - ProQR Therapeutics N.V.

ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement

LEIDEN, Netherlands and CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to...

News Image
3 months ago - ProQR Therapeutics N.V.

ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares

LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to...

News Image
3 months ago - ProQR Therapeutics N.V.

ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society

LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to...

News Image
4 months ago - ProQR Therapeutics N.V.

ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference

LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to...

News Image
5 months ago - InvestorPlace

PRQR Stock Earnings: ProQR Therapeutics Beats EPS, Misses Revenue for Q2 2024

PRQR stock results show that ProQR Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

News Image
5 months ago - BusinessInsider

PRQR Stock Earnings: ProQR Therapeutics Beats EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips ProQR Therapeutics (NASDAQ:PRQR) just reported results for the second quarter o...

News Image
8 months ago - ProQR Therapeutics N.V.

ProQR Announces First Quarter 2024 Operating and Financial Results

Preclinical proof of concept data for the AX-0810 program targeting NTCP for cholestatic diseases presented at ASGCT 27th Annual Meeting – Management to...

News Image
9 months ago - ProQR Therapeutics N.V.

ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to...

News Image
9 months ago - ProQR Therapeutics N.V.

ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to...

News Image
9 months ago - ProQR Therapeutics N.V.

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to...

News Image
10 months ago - ProQR Therapeutics N.V.

ProQR Announces Year End 2023 Operating and Financial Results

Preclinical and translational pipeline program data for AX-0810 for Cholestatic Diseases targeting NTCP and AX-1412 for Cardiovascular Disease targeting...

News Image
a year ago - ProQR Therapeutics N.V.

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024

Platform demonstrates robust in vivo editing capabilities reporting up to 70% editing of ACTB in the liver of non-human primates (NHPs) and miceFunctional...